In the BioHarmony Drug Report Database

"Preview" Icon

Darunavir

Prezista (darunavir) is a small molecule pharmaceutical. Darunavir was first approved as Prezista on 2006-06-23. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections. Prezista’s patent is valid until 2026-12-26 (FDA).

 

Trade Name

 

Prezista
 

Common Name

 

darunavir
 

ChEMBL ID

 

CHEMBL1323
 

Indication

 

acquired immunodeficiency syndrome, hiv infections
 

Drug Class

 

Antivirals: HIV protease inhibitors (saquinavir type)

Image (chem structure or protein)

Darunavir structure rendering